Complejo Hospitalario de Salamanca
In research, Complejo Hospitalario de Salamanca stands highest in Medicine (#3,772 of 10,443 worldwide) and Health Sciences (#5,157 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cardiology and Cardiovascular Medicine — Cardiology and Cardiovascular Medicine is 5.6× its share of world research.
- World rank, 2022–2025
- #12,306 of 28,054 · #11,004 all time
- Rank in Spain
- #325 of 658
- Research works
- 2.6k ◆ 0% vs 2013–17
- Citations
- 25k 9.7 per fractional work
- Top-10% rate
- 6.7% record average 16.5%
- Open access
- 28% world 28%
What is Complejo Hospitalario de Salamanca known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,772 of 10,443 | 6.6% | 270 | #3316 | |
| Health SciencesDomain | #5,157 of 11,982 | 6.5% | 285 | #4208 |
Each strip is that field’s whole ranked pool, with the notch where Complejo Hospitalario de Salamanca sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Complejo Hospitalario de Salamanca specialise in?
Where its research is concentrated relative to its size: Cardiology and Cardiovascular Medicine takes 5.6× the share of its output that it takes of world research.
- Cardiology and Cardiovascular MedicineSubfield · 21.5 works5.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Immunology and Microbiology 3.7×
- Veterinary 3.0×
- Neuroscience 1.6×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Health Professions 1.1×
- Dentistry 1.0×
- Nursing 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Psychology 0.5×
- Arts and Humanities 0.3×
- Agricultural and Biological Sciences 0.2×
- Economics, Econometrics and Finance 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Chemistry 0.1×
- Computer Science 0.1×
- Business, Management and Accounting 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Materials Science 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at Complejo Hospitalario de Salamanca?
Ranked on the composite score, Ramón García‐Sánz, Dolores Caballero and Jesús Hernández Hernández lead among researchers whose main affiliation is Complejo Hospitalario de Salamanca.
- 1 Ramón García‐Sánz Spain · #81,226 worldwide 345 citations · 78 works
- 2 Dolores Caballero Spain · #101,317 worldwide 156 citations · 35 works
- 3 Jesús Hernández Hernández Spain · #115,911 worldwide 153 citations · 24 works
- 4 Juan Jesús Cruz Spain · #240,555 worldwide 66 citations · 49 works
- 5 Lourdes Vázquez Spain · #512,754 worldwide 69 citations · 27 works
- 6 Ángel Batuecas Caletrío Spain · #549,689 worldwide 24 citations · 24 works
- 7 Antonio Rodríguez Pérez Spain · #642,613 worldwide 1 citations · 30 works
- 8 Rosa Cordovilla Spain · #725,754 worldwide 21 citations · 23 works
- 9 Miguel Barrueco Ferrero Spain · #775,415 worldwide 22 citations · 17 works
- 10 J. Gonçalves Spain · #845,750 worldwide 5 citations · 16 works
Which keywords describe research at Complejo Hospitalario de Salamanca?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Prognostic Factors, Rituximab, Chemotherapy, Echocardiography and Immunotherapy.
- Skin Cancer
- Endoscopic Surgery
- TGF-ß
- Minimal Residual Disease
- Molecular Profiling
- Cerebellum
- Clinical Management
- Survival Analysis
- Pathogenesis
- Autoantibodies
- Complications
- Heart Failure
- Echocardiography
- Genetic Mutations
- Management
- Guidelines
- Immunotherapy
- Quality of Life
- Prognostic Factors
- Treatment
- Epidemiology
- Diagnosis
- Inflammation
- Chemotherapy
- Risk Factors
- Neurological Disorders
- Cardiovascular Disease
- Rituximab
- Surgical Management
- Clinical Practice Guidelines
- Chronic Kidney Disease
- Hematopoietic Stem Cells
- Prognosis
- Neuroimaging
- Lymphoma
- Vestibular
- Genetic Alterations
- Cardiac Imaging
- Tumor Staging
- Gene Expression Profiling
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology46▲ 3.2×98 topics
- Treatment23▲ 5.2×40 topics
- Diagnosis22▲ 6.5×31 topics
- Prognostic Factors17▲ 11×14 topics
- Inflammation16▲ 2.2×54 topics
- Quality of Life12▲ 2.3×31 topics
- Chemotherapy12▲ 4.7×22 topics
- Immunotherapy12▲ 4.5×18 topics
- Risk Factors11▲ 2.7×22 topics
- Guidelines10▲ 6.0×11 topics
- Neurological Disorders10▲ 4.8×16 topics
- Management10▲ 3.5×23 topics
- Cardiovascular Disease10▲ 2.4×24 topics
- Genetic Mutations10▲ 6.1×19 topics
- Rituximab10▲ 17×4 topics
- Echocardiography9▲ 9.2×8 topics
- Surgical Management9▲ 6.1×16 topics
- Heart Failure8▲ 5.4×12 topics
- Clinical Practice Guidelines8▲ 4.2×14 topics
- Complications8▲ 4.3×13 topics
- Chronic Kidney Disease7▲ 8.3×7 topics
- Autoantibodies7▲ 8.3×8 topics
- Hematopoietic Stem Cells7▲ 22×3 topics
- Pathogenesis7▲ 3.8×17 topics
- Prognosis7▲ 5.7×9 topics
- Survival Analysis7▲ 6.7×6 topics
- Neuroimaging7▲ 6.7×6 topics
- Clinical Management6▲ 9.9×8 topics
- Lymphoma6▲ 9.4×4 topics
- Cerebellum5▲ 30×1 topic
- Vestibular5▲ 45×1 topic
- Molecular Profiling5▲ 14×3 topics
- Genetic Alterations5▲ 17×2 topics
- Minimal Residual Disease5▲ 19×2 topics
- Cardiac Imaging5▲ 11×3 topics
- TGF-ß5▲ 8.5×4 topics
- Tumor Staging4▲ 11×2 topics
- Endoscopic Surgery4▲ 12×3 topics
- Gene Expression Profiling4▲ 15×2 topics
- Skin Cancer4▲ 16×2 topics
Which research topics does Complejo Hospitalario de Salamanca publish most on?
By volume in 2022–2025: Vestibular and auditory disorders, Amyloidosis: Diagnosis, Treatment, Outcomes, Multiple Myeloma Research and Treatments and Lymphoma Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Vestibular and auditory disorders Neurology 5 works
- 2 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 4 works
- 3 Multiple Myeloma Research and Treatments Hematology 4 works
- 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 5 Acute Myeloid Leukemia Research Hematology 4 works
- 6 Cutaneous Melanoma Detection and Management Oncology 4 works
- 7 Hematopoietic Stem Cell Transplantation Hematology 3 works
- 8 Nail Diseases and Treatments Epidemiology 3 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 3 works
- 10 Cutaneous lymphoproliferative disorders research Dermatology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Complejo Hospitalario de Salamanca's research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Salamanca
- Universidad de Salamanca
- Universidad Pontificia de Salamanca
- Instituto de Investigación Biomédica de Salamanca
- Centro de Investigación del Cáncer
- Instituto de Recursos Naturales y Agrobiología de Salamanca
- Asociación Universitaria Iberoamericana de Postgrado
- Red Temática de Investigación Cooperativa en Cáncer
- Itelsa (Spain)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.